Categories
Archives
- 2026
- 2025
- 2024
- 2023
Oct
29
UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
Oct
27
Generalized myasthenia gravis management with shared decision-making
Oct
25
BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
Oct
23
Multidisciplinary Collaboration as the Future of Patient-Centered Care
Oct
14
Innovative Collaborations: Enhancing Epilepsy Care through UCB and Morehouse's Community-Based Approach
Oct
14
Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior
Oct
13
Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)
Oct
03
From Bandages to Bravery: HS Patients Command Times Square in Unforgettable Event
Sep
17
BIMZELX® (bimekizumab-bkzx) New Three-year Data in Hidradenitis Suppurativa at EADV Showed Sustained Symptom Relief Across Multiple Clinical Endpoints